Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2012
07/10/2012US8217171 Antiviral agents
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217058 Substituted piperidino phenyloxazolidinones
07/10/2012US8217038 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
07/10/2012US8217037 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
07/10/2012US8217036 Triazine compounds as PI3 kinase and mTOR inhibitors
07/10/2012US8217035 Pyrimidine derivatives used as PI-3-kinase inhibitors
07/10/2012US8217028 1,2,4-oxadiazole indole compounds
07/10/2012US8216973 2-[(1H-pyrazole-4-ylmethyl)-sulfonyl]-oxazole-derivative, 2-[(1H-pyrazole-4-ylmethyl)-sulfanyl]-oxazole-derivatives, and chiral 2-[(1H-pyrazole-4-ymethyl)sulfinyl]oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
07/10/2012CA2564062C Indole derivative having piperidine ring
07/10/2012CA2543820C Methods for synthesizing quinolinone compounds
07/10/2012CA2542909C 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
07/10/2012CA2526430C Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
07/10/2012CA2520893C Process for the preparation of 1-n-(phenyl)-2-n-(phenyl)pyrrolidine-1,2-dicarboxamide derivatives and 1-(phenylcarbamoyl)pyrrolidine-2-carboxylic acid derivatives as intermediates
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/10/2012CA2470427C Compositions and methods for treating heart failure
07/05/2012WO2012092409A2 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012090220A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012090138A1 Processes for the preparation of iloperidone
07/05/2012WO2012090043A1 Novel solid state forms of azilsartan medoxomil and preparation thereof
07/05/2012WO2012089633A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
07/05/2012WO2012089601A1 New biaryl amide derivatives
07/05/2012WO2012064943A3 Metalloenzyme inhibitor compounds
07/05/2012WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
07/05/2012US20120172615 Isoxazoline-substituted benzamide compound and pesticide
07/05/2012US20120172600 Method for preparation of iloperidone and crystallization method thereof
07/05/2012US20120172592 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprosing these forms
07/05/2012US20120172401 Benzimidazole derivative and use as angiotensin ii antagonist
07/05/2012US20120172400 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
07/05/2012US20120172372 Ureas and Their Use in the Treatment of Heart Failure
07/05/2012US20120172361 Triazine derivatives and their therapeutical applications
07/05/2012US20120172360 Novel 1h-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of akt (pkb) phosphorylation
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172358 GPCR Agonists
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/05/2012US20120172351 Novel fused cyclic compound and use thereof
07/05/2012US20120172348 Sterol derivative
07/05/2012US20120172345 Heteroaryls and uses thereof
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172217 Pesticidal compositions
07/05/2012US20120171183 Arthropodicidal anthranilamides
07/05/2012US20120170098 Chromene compound
07/05/2012CA2822556A1 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012CA2822188A1 New biaryl amide derivatives
07/05/2012CA2820854A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
07/04/2012EP2471792A1 3-(biaryloxy) propionic acid derivative
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
07/04/2012EP2470527A1 Ether benzotriazole derivatives
07/04/2012EP2470524A1 Pyrrolidine derivatives as nk3 receptor antagonists
07/04/2012EP2470522A1 Np-1 antagonists and their therapeutic use
07/04/2012EP2470520A1 Chromone derivatives, a process for their preparation and their therapeutic applications
07/04/2012EP2470511A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470183A2 Heterocyclic amide compounds as protein kinase inhibitors
07/04/2012EP2262799B1 Pyridine compounds
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012CN1953965B Novel cis-imidazolines
07/04/2012CN1894242B Novel oxazolidinone derivatives
07/04/2012CN1845911B Condensed ring compound and use thereof
07/04/2012CN1832928B 5-membered heterocycle-based p38 kinase inhibitors
07/04/2012CN102548989A Sphingosine-1-phosphate receptor agonists
07/04/2012CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
07/04/2012CN102548977A Sulfone derivative
07/04/2012CN102548976A (Thio) morpholine derivatives as S1P modulators
07/04/2012CN102548975A Histone deacetylase inhibitors
07/04/2012CN102548974A Novel FXR (NR1H4 ) binding and activity modulating compounds
07/04/2012CN102548970A Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as AKT (PKB) phosphorylation inhibitors
07/04/2012CN102548557A Compounds for the reduction of beta-amyloid production
07/04/2012CN102532535A Conductive composition, preparing method thereof, polymer and electrode, electrolyte membrane and fuel cell
07/04/2012CN102532120A 埃坡霉素(epothilone)，合成埃坡霉素的中间体，其类似物及其用途 Epothilones (epothilone), the synthesis of epothilone intermediates, analogs and their use
07/04/2012CN102532116A Synthesis method of anti-tumor targeted therapeutic drug tivozanib
07/04/2012CN102532115A Synthetic method of 4-alkylene oxide-3-aryl sydnone category compound
07/04/2012CN102532103A Quinazolinyl aryl urea derivatives and preparation method and application thereof
07/04/2012CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
07/04/2012CN102532050A Preparation method for 2-amido substitutional oxazole (thioazole) derivative
07/04/2012CN102532048A Isoxazoline-substituted benzamide compound and pesticide
07/04/2012CN102532024A Sinomenine derivative
07/04/2012CN102532009A Compounds for inhibiting dipeptidyl peptidase, preparation method for compounds and application of compounds
07/04/2012CN102060852B Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization
07/04/2012CN101759691B Crown ether substitutional amino acid schiff base and transition metal complex and preparation method thereof
07/04/2012CN101687860B Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
07/04/2012CN101622251B Salt of heterocycle-substituted pyridine derivative or crystal thereof
07/04/2012CN101528737B Novel heteroaryl carboxamides
07/04/2012CN101506165B Phenyl, pyridine and quinoline derivatives
07/04/2012CN101492444B Nitrogenous heterocyclic compounds with insecticidal activity, preparation and uses thereof
07/04/2012CN101370496B Novel thiophene derivatives as S1P1/EDG1 receptor agonists
07/04/2012CN101248064B Nitrocatechol derivatives as COMT inhibitors
07/03/2012US8211932 Organic compounds and their uses
07/03/2012US8211928 Hepatitis C virus inhibitors
07/03/2012US8211926 Bicyclic pyrazolo-heterocycles
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211920 6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
07/03/2012US8211919 Amide derivatives as rock inhibitors
07/03/2012US8211914 Inhibitors of diacylglycerol acyltransferase
07/03/2012US8211896 Aryl sulfonamides
07/03/2012US8211884 2,2-Dimethyl-4-oxo-4-(4-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-[1,4]diazepan-1-yl)-butyric acid, hydrochloride; obesity, type II diabetes mellitus and metabolic syndrome
07/03/2012CA2564355C Protein kinase modulators and method of use
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 647